Work

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Year: 2010

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/leu.2010.190

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Mayo Clinic, Celgene, National Cancer Institute

Awards: G3470051022, Comparative Pharmaco-oncogenomics of Myeloma Drug Resistance

OpenAlex ID: W1968654086

FWCI: 15.27

Cites: 17

Cited by: 198

Related to: 10